Chemistry:CUMYL-BC-HPMEGACLONE-221
From HandWiki
Short description: Chemical compound
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
Chemical and physical data | |
Formula | C28H30N2O |
Molar mass | 410.561 g·mol−1 |
3D model (JSmol) | |
| |
|
Cumyl-BC-HpMeGaClone-221 (Cumyl-BC[2.2.1]HpMeGaClone, SGT-271) is a gamma-carboline derivative which is a synthetic cannabinoid that has been sold as a designer drug.[1] It was first identified in Germany in September 2020.[2]
See also
References
- ↑ "Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights". Acta Bio-Medica 92 (6): e2021546. January 2022. doi:10.23750/abm.v92i6.12696. PMID 35075053.
- ↑ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-558-4. https://www.emcdda.europa.eu/system/files/publications/13464/20205648_TD0320796ENN_PDF_rev.pdf.
Original source: https://en.wikipedia.org/wiki/CUMYL-BC-HPMEGACLONE-221.
Read more |